期刊文献+

慢性乙型病毒性肝炎、肝癌组织HLA-Ⅰ类抗原的表达及意义

Hepatic tissue expression of HLA-I in patients with chronic hepatitis B virus and hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨慢性乙型肝炎、肝癌组织中人类白细胞抗原I(HLA-I)的表达和临床意义。方法:应用流式细胞仪对51例慢性乙型肝炎患者肝组织和43例原发性肝癌癌组织中的HLA-I抗原进行检测。结果:肝癌组织中HLA-I抗原表达为36.47±19.38,明显低于慢性乙肝的79.54±41.55和正常肝组织的81.86±46.53(P均<0.01),而慢性乙型肝炎肝组织和正常肝组织HLA-I类抗原表达无明显差异(P>0.05),伴有肝内和(或)淋巴结转移的肝癌组织中HLA-I抗原表达较无转移组明显降低(22.83±11.59 vs 46.28±23.16,P<0.05);HLA-I类抗原表达与血清AFP水平呈明显负相关(r=-0.741 1,P<0.01),但与肝癌组织分化程度呈明显正相关(r=0.805 1,P<0.05)。结论:HLA-I抗原表达异常与肝癌的发生和转移密切相关。 Objective: To study the expression of human leucocyte antigen Ⅰ(HLA-Ⅰ ) in patients with hepatitis B virus infection and hepatocelhlar carcinoma. Method: HLA-Ⅰ in 51 liver tissues of viral hepatitis B and 43 tumor tissues of hepatocellular carcinoma was examined by flow eytometry. Results: The expression of HLA-Ⅰ was lower in tumor tissue of hepatocelhlar carcinoma(36.47 ± 19.38) than that in liver tissue of chronic viral hepatitis B (79.54 ± 41.55, P 〈 0.01 ) and normal liver tissues(81.86 ± 46.53, P 〈 0.01 ), but no significant difference was found between the normal liver tissues and tissues of chronic viral hepatitis( P 〉 0.05). Moreover, the expression of HLA-Ⅰ in tumor tissues with lymphnode involvement was lower than in tumors without involvement(22.83 ± 11.59 vs 46.28±23.16) ( P 〈0.05). There was a reverse relation between the expression of HLA-Ⅰ and the level of serum alpha fetoprotein ( r = - 0.741 1, P 〈 0.01 ), but a positive relation was found between with histological differentiation grading( r =0.805 1, P 〈0.05). Conclusion: Low expression of HLA-Ⅰ is relation to development and metastasis of hepatocellular carcinoma.
出处 《山东大学学报(医学版)》 CAS 北大核心 2006年第4期357-359,363,共4页 Journal of Shandong University:Health Sciences
基金 山东省青年科学家基金资助课题(03BS035)
关键词 HLA-Ⅰ类抗原 肝炎 乙型 肝细胞 HLA-Ⅰ antigens Hepatitis B Carcinoma, hepatocellular
  • 相关文献

参考文献9

二级参考文献35

  • 1病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 2[1]Daniel J H,Francesco MM,Soldano F.HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story[J].Mol Med Today,1999,5: 178-186.
  • 3[2]Alessandro S,Robert C,John F.HLA expression in cancer: Implications for T cell-based immunotherapy [ J ].Immunogenetics,2001,53: 255-263.
  • 4[3]Ohnmacht GA,Marincola FM.Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma[J].J Cell Physiol,2000,182: 332-338.
  • 5[4]Ikeda H,Lethe B,Lehmann F,et al.Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor[ J].Immunity,1997,6: 199-208.
  • 6[5]Sykulev Y,Joo M,Vturina I,et al.Evidence that a single peptide-MHC complex on a target cell can elicit acytolytic T cell response[J].Immunity,1996,4: 565-571.
  • 7[6]Pratap M,Jack LS.Perfusion chromatography for very rapid purification of class I and Ⅱ MHC proteins[ J].J Immunolo Methods,2000,234: 83-88.
  • 8[7]Yuki N,Hiroeki S,Kazuhiro S,et al.Induction of CTL from peripheral blood of HLA-A31 + gastric cancer patients by in vitro stimulation with antigenic peptide of signet ring cell carcinoma[J].Jpn J Cancer Res,2000,91: 616-621.
  • 9[8]Schirle M,Keilholz W,Weber B,et al.Identification of tumorassociated MHC class I Iigands by a novel T cell-independent approach[J].Eur J Immunol,2000,30(8): 2216-2225
  • 10[9]Kessler JH,Beekman NJ,Bres-Vloemans SA,et al.Efficient identification of novel HLA-A ( * ) 0201 -presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis[ J].J Exp Med,2001,193(1): 73-88.

共引文献14024

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部